会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHODS OF ENHANCING IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND COMPOUNDS USEFUL IN THE METHODS
    • 在方法中有用的增强室内容物和化合物中的免疫应答的方法
    • WO2005074460A3
    • 2005-09-29
    • PCT/US2004041021
    • 2004-12-06
    • BECTON DICKINSON COCAMPBELL ROBERTDOLAN KEVIN GALARCON JASONWOODLEY WENDY DMIKSZTA JOHN
    • CAMPBELL ROBERTDOLAN KEVIN GALARCON JASONWOODLEY WENDY DMIKSZTA JOHN
    • A61K31/7048A61K39/00A61K39/39A61K45/00A61K47/00G01N33/53
    • A61K39/39A61K31/7048A61K39/12A61K39/145A61K2039/55511A61K2039/55516A61K2039/55555A61K2039/55588C12N2760/16134
    • The present invention relates to immunogenic compositions for intradermal delivery of an antigenic or immunogenic agent in combination with one or more excipients. The immunogenic compositions of the invention comprise an antigenic or immunogenic agent and at least one excipient which acts as an adjuvant, i.e., enhances the immune response to the antigenic or immunogenic agent, once delivered to the intradermal compartment of a subject's skin. The immunogenic compositions of the invention comprise an excipient which when administered to the intradermal compartment of skin in accordance with the invention demonstrate adjuvant activity. The immunogenic compositions of the invention have enhanced efficacy as the excipients of the composition cause an asymptomatic skin irritation and recruit antigen presenting cells to the intradermal compartment and thus enhance presentation and/or availability of the antigenic or immunogenic agent to the antigen presenting cells. The enhanced efficacy of the immunogenic compositions of the invention may result in a therapeutically effective immune response after a single intradermal dose, with lower doses of antigenic or immunogenic agent than conventionally used, and without the need for booster immunizations
    • 本发明涉及用于皮内递送抗原性或免疫原性试剂与一种或多种赋形剂组合的免疫原性组合物。 本发明的免疫原性组合物包含抗原或免疫原性试剂和至少一种充当佐剂的赋形剂,即一旦递送到受试者的皮肤的真皮内隔室,则增强对抗原或免疫原性试剂的免疫应答。 本发明的免疫原性组合物包含赋形剂,其当根据本发明施用于皮肤的皮内隔室时显示佐剂活性。 本发明的免疫原性组合物具有增强的功效,因为组合物的赋形剂引起无症状的皮肤刺激并将抗原呈递细胞募集到皮内区室,从而增强抗原呈递细胞的抗原或免疫原性的呈递和/或可用性。 本发明的免疫原性组合物的增强的功效可以在单次真皮内剂量之后产生治疗有效的免疫应答,具有比常规使用的更低剂量的抗原性或免疫原性试剂,并且不需要加强免疫
    • 2. 发明申请
    • METHODS OF ENHANCING IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND COMPOUNDS USEFUL IN THE METHODS
    • 在方法中有用的增强室内容物和化合物中的免疫应答的方法
    • WO2005074460A9
    • 2006-08-24
    • PCT/US2004041021
    • 2004-12-06
    • BECTON DICKINSON COCAMPBELL ROBERTDOLAN KEVIN GALARCON JASONWOODLEY WENDY DMIKSZTA JOHN
    • CAMPBELL ROBERTDOLAN KEVIN GALARCON JASONWOODLEY WENDY DMIKSZTA JOHN
    • A61K39/00A61K31/7048A61K39/39A61K45/00A61K47/00G01N33/53
    • A61K39/39A61K31/7048A61K39/12A61K39/145A61K2039/55511A61K2039/55516A61K2039/55555A61K2039/55588C12N2760/16134
    • The present invention relates to immunogenic compositions for intradermal delivery of an antigenic or immunogenic agent in combination with one or more excipients. The immunogenic compositions of the invention comprise an antigenic or immunogenic agent and at least one excipient which acts as an adjuvant, i.e., enhances the immune response to the antigenic or immunogenic agent, once delivered to the intradermal compartment of a subject's skin. The immunogenic compositions of the invention comprise an excipient which when administered to the intradermal compartment of skin in accordance with the invention demonstrate adjuvant activity. The immunogenic compositions of the invention have enhanced efficacy as the excipients of the composition cause an asymptomatic skin irritation and recruit antigen presenting cells to the intradermal compartment and thus enhance presentation and/or availability of the antigenic or immunogenic agent to the antigen presenting cells. The enhanced efficacy of the immunogenic compositions of the invention may result in a therapeutically effective immune response after a single intradermal dose, with lower doses of antigenic or immunogenic agent than conventionally used, and without the need for booster immunizations
    • 本发明涉及用于皮内递送抗原性或免疫原性试剂与一种或多种赋形剂组合的免疫原性组合物。 本发明的免疫原性组合物包含抗原或免疫原性试剂和至少一种充当佐剂的赋形剂,即一旦递送到受试者的皮肤的真皮内隔室,则增强对抗原或免疫原性试剂的免疫应答。 本发明的免疫原性组合物包含赋形剂,其当根据本发明施用于皮肤的皮内隔室时显示佐剂活性。 本发明的免疫原性组合物具有增强的功效,因为组合物的赋形剂引起无症状的皮肤刺激并将抗原呈递细胞募集到皮内区室,从而增强抗原呈递细胞的抗原或免疫原性的呈递和/或可用性。 本发明的免疫原性组合物的增强的功效可以在单次真皮内剂量之后产生治疗有效的免疫应答,具有比常规使用的更低剂量的抗原性或免疫原性试剂,并且不需要加强免疫
    • 5. 发明申请
    • METHODS FOR INTRADERMAL DELIVERY OF THERAPEUTICS AGENTS
    • 治疗剂的皮内递送方法
    • WO2005023328A3
    • 2005-11-10
    • PCT/US2004019118
    • 2004-06-14
    • BECTON DICKINSON COPETTIS RONALD JHARVEY ALFREDCAMPBELL ROBERTMIKSZTA JOHNBRITTINGHAM JOHN
    • PETTIS RONALD JHARVEY ALFREDCAMPBELL ROBERTMIKSZTA JOHNBRITTINGHAM JOHN
    • A61K31/496A61K38/20A61K38/21A61K39/395A61K45/00A61M20060101A61M23/00
    • A61K9/0021A61K9/0019
    • The present invention relates to methods and devices for delivering one or more biologically active agents, particularly therapeutic agents, the intradermal compartment of a subject's skin. The present invention provides an improved method of delivery of biologically active agents, such as therapeutic agents, through lymphatic vasculature accessed by intradermal delivery. Therapeutic agents to be delivered in accordance with the present invention include, but are not limited ton antineoplastic agents, chemotherapeutic agents, antibodies, antibiotics, anti-angiogenesis agents, anti-inflammatory agents, and immunotherapeutic agents. Therapeutic agents delivered in accordance with the present invention have improved bioavailability, including improved systemic distribution and improved delivery to particular tissues. Therapeutic agents, delivered in accordance with the methods of the invention have an improved clinical utility and therapeutic efficacy relative to other drug delivery methods, including intraperitoneal, intramuscular and subcutaneous delivery. The methods of the present invention provide benefits and improvements over convention drug delivery methods including dose sparing, increased drug efficacy, reduced side effects, reduced metastatic potential and prolonged survival.
    • 本发明涉及用于递送一种或多种生物活性剂,特别是治疗剂,受试者皮肤的皮内隔室的方法和装置。 本发明提供了通过皮内递送进入的淋巴脉管系统递送生物活性剂如治疗剂的改进方法。 根据本发明递送的治疗剂包括但不限于抗肿瘤剂,化学治疗剂,抗体,抗生素,抗血管生成剂,抗炎剂和免疫治疗剂。 根据本发明递送的治疗剂具有改善的生物利用度,包括改善的全身分布和改善的递送至特定组织。 根据本发明的方法递送的治疗剂相对于其他药物递送方法(包括腹膜内,肌肉内和皮下递送)具有改善的临床效用和治疗功效。 本发明的方法提供了优于常规药物递送方法的益处和改进,包括剂量节省,药物效力增加,副作用减少,转移潜能降低和存活时间延长。